Providers are urging the CMS not to finalize a rule that could prevent patients from taking infusion drugs at home. If the agency moves forward with the plan, it could lead to higher Medicare costs as more patients may need to seek treatment at…
Providers worry CMS rule will limit infusion drug use at home
